Skip to main content
Livermore
Livermore
ZHEN

Olema Pharmaceuticals, Inc.

OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001750284

In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.

Q2 2024 vs. Q1 2024

How the institutions holding Olema Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of OLMA: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders1261129+4
Shares56.1M47.4K57.9M+1.87M (+3.3%)
Value$635.2M$537.1K$626.9M−$7.75M (−1.2%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Olema Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to OLMA in Q2 2024
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.3,211,927$34.8M0.11%
Great Point Partners LLC796,880$8.62M1.65%
Boxer Capital, LLC650,000$7.03M0.37%
Affinity Asset Advisors, LLC275,000$2.98M0.47%
Schroder Investment Management Group159,739$1.73M0.00%
Trexquant Investment LP114,642$1.24M0.02%
Hennion & Walsh Asset Management, Inc.87,312$944.7K0.05%
Dana Investment Advisors, Inc.74,657$807.8K0.03%
Renaissance Technologies LLC53,200$575.6K0.00%
Envestnet Asset Management Inc49,220$532.6K0.00%
Deerfield Management Company, L.P. (Series C)31,405$339.8K0.01%
Jump Financial, LLC30,592$331.0K0.01%
Pitcairn Co27,013$292.3K0.02%
Brevan Howard Capital Management LP22,328$241.6K0.02%
Corebridge Financial, Inc.21,480$232.4K0.00%
ADAR1 Capital Management, LLC20,076$217.2K0.04%
Mirae Asset Global ETFs Holdings Ltd.16,856$183.9K0.00%
Alpine Global Management, LLC15,857$171.6K0.03%
Corton Capital Inc.14,377$155.6K0.08%
Cubist Systematic Strategies, LLC13,416$145.2K0.00%
Bayesian Capital Management, LP12,129$131.2K0.02%
Amundi1,839$19.6K0.00%
The PNC Financial Services Group, Inc.1,414$15.3K0.00%
NBC Securities, Inc.1,248$13.0K0.00%
Umb Bank N A1,025$11.1K0.00%
Huntington National Bank644$6.97K0.00%
Signaturefd, LLC162$1.75K0.00%
First Horizon Advisors, Inc.87$9410.00%
Rothschild Investment LLC10$1080.00%

Sold out (25)

Institutions that held Olema Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of OLMA in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Braidwell LP704,344$7.97M
Altium Capital Management LP605,000$6.85M
Ally Bridge Group (NY) LLC559,035$6.33M
Exome Asset Management LLC143,400$1.62M
Monashee Investment Management LLC135,000$1.53M
Acadian Asset Management LLC103,179$1.17M
Millennium Management LLC88,257$999.1K
VR Adviser, LLC77,042$872.1K
Hudson Bay Capital Management LP67,507$764.2K
Cinctive Capital Management LP56,518$639.8K
Algert Global LLC33,580$380.1K
Prelude Capital Management, LLC32,700$370.2K
Gsa Capital Partners LLP27,013$306.0K
Susquehanna Fundamental Investments, LLC15,565$176.2K
Entropy Technologies, LP14,246$161.3K
E Fund Management Co., Ltd.13,927$157.7K
American International Group, Inc.13,231$149.8K
Walleye Capital LLC11,966$135.5K
Sherbrooke Park Advisers LLC11,212$126.9K
Quest Partners LLC8,215$93.0K
Metropolitan Life Insurance Co1,545$17.5K
Truvestments Capital LLC1,323$15.0K
Comerica Bank354$4.01K
US Bancorp157$1.78K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC6$67

Not filed for Q2 2024 yet (1)

Institutions that held Olema Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OLMA in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG47,446$537.1K